Kuss B - Search Results

1

Dipeptidyl peptidase 8 and 9--guilty by association?

Pitman MR, Sulda ML, Kuss B, Abbott CA. Pitman MR, et al. Among authors: kuss b. Front Biosci (Landmark Ed). 2009 Jan 1;14(10):3619-33. doi: 10.2741/3476. Front Biosci (Landmark Ed). 2009. PMID: 19273298 Free article. Review.

2

Real-world experience of Australian and New Zealand patients with chronic lymphocytic leukemia and mantle cell lymphoma accessing ibrutinib through a Named Patient Program.

Mulligan SP, Opat S, Cheah CY, Kuss B, Hertzberg M, Marlton P, Poplar S, Puig A, McGeachie M, Weinkove R, Tam CS. Mulligan SP, et al. Among authors: kuss b. Leuk Lymphoma. 2023 Feb;64(2):312-318. doi: 10.1080/10428194.2022.2148220. Epub 2022 Nov 24. Leuk Lymphoma. 2023. PMID: 36423351

3

Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia.

Allan JN, Flinn IW, Siddiqi T, Ghia P, Tam CS, Kipps TJ, Barr PM, Elinder Camburn A, Tedeschi A, Badoux XC, Jacobs R, Kuss BJ, Trentin L, Zhou C, Szoke A, Abbazio C, Wierda WG. Allan JN, et al. Among authors: kuss bj. Clin Cancer Res. 2023 Jul 14;29(14):2593-2601. doi: 10.1158/1078-0432.CCR-22-2779. Clin Cancer Res. 2023. PMID: 37282671 Free PMC article.

4

Expression and prognostic assessment of dipeptidyl peptidase IV and related enzymes in B-cell chronic lymphocytic leukemia.

Sulda ML, Abbott CA, Macardle PJ, Hall RK, Kuss BJ. Sulda ML, et al. Cancer Biol Ther. 2010 Jul 15;10(2):180-9. doi: 10.4161/cbt.10.2.12168. Epub 2010 Jul 26. Cancer Biol Ther. 2010. PMID: 20534982

5

Clinical utility of molecular and flow cytometric markers in chronic lymphocytic leukaemia.

Sulda ML, Kuss BJ, Hall RK, Bailey S, Macardle PJ. Sulda ML, et al. Among authors: kuss bj. Intern Med J. 2012 Feb;42(2):137-46. doi: 10.1111/j.1445-5994.2010.02294.x. Epub 2010 Jun 16. Intern Med J. 2012. PMID: 20561095

6

From genome to proteome: Looking beyond DNA and RNA in chronic lymphocytic leukemia.

Thurgood LA, Chataway TK, Lower KM, Kuss BJ. Thurgood LA, et al. J Proteomics. 2017 Feb 23;155:73-84. doi: 10.1016/j.jprot.2017.01.001. Epub 2017 Jan 6. J Proteomics. 2017. PMID: 28069558 Review.

7

Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil.

Tam C, Kuss B, Opat S, Boulos J, Marlton P. Tam C, et al. Among authors: kuss b. Intern Med J. 2017 Jul;47 Suppl 4:5-10. doi: 10.1111/imj.13493. Intern Med J. 2017. PMID: 28685928 Review.

8

Development of locus specific sub-clone separation by fluorescence in situ hybridization in suspension in chronic lymphocytic leukemia.

Do CH, Bailey S, Macardle C, Thurgood LA, Lower KM, Kuss BJ. Do CH, et al. Cytometry A. 2017 Nov;91(11):1088-1095. doi: 10.1002/cyto.a.23264. Epub 2017 Oct 11. Cytometry A. 2017. PMID: 29024486 Free article.

9

Trisomy 12 assessment by conventional fluorescence in-situ hybridization (FISH), FISH in suspension (FISH-IS) and laser scanning cytometry (LSC) in chronic lymphocytic leukemia.

Do CH, Lower KM, Macardle C, Kuss BJ. Do CH, et al. Cancer Genet. 2017 Oct;216-217:142-149. doi: 10.1016/j.cancergen.2017.07.009. Epub 2017 Aug 4. Cancer Genet. 2017. PMID: 29025588

10

Management of high risk chronic lymphocytic leukaemia (CLL) patients in Australia.

Kuss BJ, Tam CS. Kuss BJ, et al. Intern Med J. 2017 Dec;47 Suppl 6:5-10. doi: 10.1111/imj.13680. Intern Med J. 2017. PMID: 29250930 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page